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Utility of Swartz Sheath in Patients with Paroxysmal Supraventricular
Tachycardia and Unsuccessful Conventional Radiofrequency Catheter
Ablation
SHULIN WU, HAIJIE LI, PINGZHEN YANG, SILIN CHEN, XIANGSHENG ZHENG, XIANZHANG ZHAN,
XIANHONG FANG AND FEIFAN OUYANG
From Department of Cardiology, Gudangdong Provincial Hospital, P. R. China

WU, ET AL.: Utility of Swartz Sheath in Patients with Paroxysmal Supraventricular Tachycardia and Unsuccessful
Conventional Radiofrequency Catheter Ablation. Objective: To investigate the effect of Swartz sheath on raising
the success rate of radiofrequency catheter ablation (RFCA) for patients with paroxysmal supraventricular tachycardia
(PSVT). Methods: In 47 patients with PSVT failed by conventional RFCA techniques, SR0 Swartz sheath was utilized
in ablation of patients with right atrial tachycardia (AT) and slow atrioventricular nodal pathway in atrioventricular
node reentrant tachycardia (AVNRT), SL1 Swartz sheath was utilized in left accessory pathway (AP) in atrioventricular
reentrant tachycardia (AVRT), SR1-3 Swartz sheath was separately utilized in different right AP. Results: RFCA of 46
patients with PSVT was successful after utilizing Swartz sheath. Conclusion: It was suggested that the use of Swartz
sheath may greatly raised the success rate of RFCA of PSVT. (J HK Coll Cardiol 1999;7:14-17)
Supraventricular tachycardia, radiofrequency catheter ablation, Swartz sheath

Introduction
Radiofrequency catheter ablation (RFCA) has
been the choice of treatment for paroxysmal
supraventricular tachycardia (PSVT) over the recent
decade with higher success rate. Due to cardiac anatomic
variation in a minority of patients, successful ablation

cannot be achieved by conventional catheter ablation
technique until supplemented with some special catheter
or sheath. We report and investigate the successful
experience of the use of Swartz sheath in 47 patients
who had failed initial procedure by conventional
mapping and ablation methods among consecutive 900
patients with PSVT in our hospital.
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Patient population
Between February 1994 and November 1998,
1050 patients underwent ablation in our hospital. In the
series of 1050 patients, the first 150 patients were
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excluded from consideration because of the learning
curve effect. Among the next 900 patients, 92 patients
underwent initial unsuccessful catheter ablation of PST.
Of 92 patients, 47 were included in this study because
they subsequently used Swartz sheath in the same
procedure in the consideration of instability of ablation
catheter or poorer tissue contact at the target site. There
were 22 men and 25 women and their mean age were
39±10 (16-66) years. The history of recurrent palpitation
ranged in duration from 1 to 26 years (mean 10±12).
Three patients had hypertensive cardiac disease. One
had coronary heart disease after the operation of
coronary artery bypass. One had Ebstein's abnormality.
All antiarrhythmic medications were discontinued 5-7
days before procedure.
Electrophysiological study and catheter ablative
procedure
Electrophysiological diagnosis and RFCA of
atrial tachycardia (AT), atrioventricular nodal reentrant
tachycardia (AVNRT) and atrioventricular reentrant
tachycardia (AVRT) were referred as previous standard
criteria1-3. Swartz sheaths of various size were inserted
via femoral veins according to different types of
tachycardia and different sites of accessory pathway
(AP) after initial unsuccessful ablation by conventional
techniques. Transeptal procedure was used in left AP
ablation4. Right anterior oblique 30 o or left anterior
oblique 45o were used as fluoroscopic projections. The
successful ablation criteria were the same as in
references 1-3.
Electrocardiography and blood pressure were monitored
for 24 hours after ablation. Aspirin 300 mg was given
orally per day for 3 months. Patients were followed up
in 1, 3, 6, 12 months after operation.

Statistics
Data are presented as mean ±SD. Difference
between initial unsuccessful attempt and subsequent
successful ablation was evaluated by paired t test. A
p value <0.05 was considered significant.

Results
Electrophysiological data
Of the 47 patients, one had intra-atrial reentrant
tachycardia (two sites, mid-lateral and inferoposterior
in the right atrium), 12 had AVNRT, 34 had AVRT. 31
of these 34 patients had one AP, 3 had more than one
AP, 3 left AP, 31 right AP. The locations of right APs
were 2 anteroseptal, 6 anterior, 19 anterolateral and 7
lateral respectively.
Utility of Swartz sheath
SR 0 was used in AT and AVNRT, SL1 in left
anterolateral wall. Of right APs, SR1, SR2, SR3 were
used in 4, 20, 7 patients respectively (Table 1).

Catheter ablative results
After the first failed ablation procedure, we
observed unstable ablation catheter under fluoroscopy
or variable recorded electrogram at target site in 47
patients. Instability of ablation catheter or inadequate
tissue contact was regarded as the failed reason5. Swartz
sheaths were used in these patients, all had successful
ablation except one with right AP. In the course of
mapping, a large coronary sinus ostium was suspected
in a patient with AVNRT. The recorded atrial
electrogram in the ablation catheter (figure 1A) varied
significantly, reflecting instability of ablation catheter

Table 1. The demography of Swartz sheaths used in 47 patients
SR0
AT
AVNRT
Left anterolateral AP
Right anteroseptal AP
Right anterior AP
Right anterolateral AP
Right lateral AP
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SR1

SR2

SR3

SL1

1
12
3
2
2

1
19
7
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that lead to initial ablation failure. After the use of SR0
sheath, the intracardiac signal (figure 1B) and the
fluoroscopic appearance (figure 2) were recorded. The
ablation catheter contacted tightly the atrial tissue in
the posteroseptal area, the change of atrial and
ventricular wave were less. Two energy application in
this area resulted in the disappearance of slow pathway
conduction. Excluding the time required to insert
catheters, obtain baseline electrophysiologic
measurements and induce and determine the mechanism

of tachycardia, during the initial attempt, the ablation
time was 42±27 minutes, the fluoroscopic time was 22±
15 minutes, the number of energy applications was
15.4± 7.2. Comparison to these, the ablation time was
22±12 minutes, the fluoroscopic time was 15±8 minutes,
the number of energy application was 3.5± 1.8 during
the subsequent ablation, the significant difference was
listed out in Table 2. No complication and recurrence
were observed after follow-up of 19± 9 months (range
4-32 months) in successful patients.

Figure 1B.
Figure 1A.
Figure 1. Recorded electrogram in a patient with AVNRT. A, Without SR0 sheath, the electrogram varied significantly, reflecting
instability of the ablation catheter. This resulted in initial failed ablation attempt. B, With sheath, stable electrogram at successful
target site was observed. lead II, aVR, V1 are surface electrocardiogram. HBEp=proximal His bundle; HBEm=middle His
bundle; HBEd=distal His bundle; CSp=proximal coronary siuns; CSm=middle coronary sinus; CSd=distal coronary sinus;
ABL=ablation catheter.

Figure 2. Right anterior oblique (left) and left anterior oblique (right) fluoroscopic appearance in the
same patient as Figure 1. With SR0 sheath, the ablation catheter contacted tightly the atrial tissue in the
posterioseptal area, two energy application in this area resulted in the disappearance of slow pathway
conduction.
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Table 2. Comparison of initial unsuccessful ablation and subsequent successful ablation

Ablation time
Fluoroscopic time
No. of energy applicaiton

Initial
unsuccessful ablation

Subsequent
sucessful ablation

P value

42±27
22±15
15.4±7.2

22±13
15±8
3.5±1.8

<0.01
<0.05
<0.01

Discussion
In this study, the use of Swartz Sheaths of various
size in 47 patients with PSVT, who underwent initial
unsuccessful ablation by conventional technique,
achieved better target mapping, and shortened
procedural time and raised the success rate.
Double ablative catheter mapping and ablation
technique has successful result in most patients with
right atrial AT, but in a few unsuccessful ablation cases
because of instability of the ablation catheter or poorer
tissue contact at the target site, the use of SR0 sheath
may get better stability and successful ablation.
Common or hardened Webster ablation catheters
generally get food stability in the slow pathway ablation
for AVNRT. In some cases, due to structural variation
of Koch's triangle area, especially in patients with large
coronary sinus ostium (CSO), ablation catheter easily
slipped into CSO. After the use of SR0 sheath, better
contact of ablation catheter and less change of A and V
waves may ablate slow pathway successfully. The
method of the use of SR0 sheath was locating the tip of
sheath near or above CSO, so ablation catheter may
anchor in the tricuspid annulus more exactly.
A few left APs locate anterolateral far away from
CSO, transaortic mapping under or above the mitral
annulus can't search for suitable target sites. Under this
circumstance, transseptal approach with the use of long
sheath should be used5. We used SL1 sheath in three
patients with left anterolateral APs.
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In the course of right APs mapping and ablation,
ablation catheter can't be stabilized in the tricuspid
annulus due to lack of clear "marker", especially right
lateral APs, APs located in the folded junction structure
between the right atrium and the right ventricle. The
various size of Swartz sheaths were used according to
different APs, target sites were mapped and ablated
correctly. The RF power was usually 30-40 Watts. Our
experience of the use of Swartz sheath is: SR1 may be
used in right anteroseptal, SR2 in right anterior, SR3 in
right anterolateral, SR3 or SR4 in right lateral, SL1 in
left anterolateral with the transseptal approach.
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